These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23174199)

  • 1. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch.
    Moon S; Wang Y; Edens C; Gentsch JR; Prausnitz MR; Jiang B
    Vaccine; 2013 Jul; 31(34):3396-402. PubMed ID: 23174199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
    Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B
    Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin Vaccination against Rotavirus Using Microneedles: Proof of Concept in Gnotobiotic Piglets.
    Wang Y; Vlasova A; Velasquez DE; Saif LJ; Kandasamy S; Kochba E; Levin Y; Jiang B
    PLoS One; 2016; 11(11):e0166038. PubMed ID: 27824918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice.
    Resch TK; Wang Y; Moon SS; Joyce J; Li S; Prausnitz M; Jiang B
    Sci Rep; 2018 Jan; 8(1):561. PubMed ID: 29330512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated human rotavirus vaccine induces heterotypic antibody response: correction and development of IgG avidity assay.
    Velasquez DE; Wang Y; Jiang B
    Hum Vaccin Immunother; 2015; 11(2):531-3. PubMed ID: 25692974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies.
    Jiang B; Wang Y; Glass RI
    Hum Vaccin Immunother; 2013 Aug; 9(8):1634-7. PubMed ID: 23744507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
    Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
    J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines.
    Wen X; Wen K; Cao D; Li G; Jones RW; Li J; Szu S; Hoshino Y; Yuan L
    Vaccine; 2014 Jul; 32(35):4420-4427. PubMed ID: 24962749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing an Inactivated Rotavirus Vaccine and Evaluating the Immunogenicity Against a Commercially Available Attenuated Rotavirus Vaccine Using a Mice Animal Model.
    Hashim AS; Aboshanab KM; El-Sayed AF
    Viral Immunol; 2016 Dec; 29(10):565-571. PubMed ID: 27860553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
    Forster AH; Witham K; Depelsenaire ACI; Veitch M; Wells JW; Wheatley A; Pryor M; Lickliter JD; Francis B; Rockman S; Bodle J; Treasure P; Hickling J; Fernando GJP
    PLoS Med; 2020 Mar; 17(3):e1003024. PubMed ID: 32181756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal influenza immunization with vaccine-coated microneedle arrays.
    Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I
    PLoS One; 2009; 4(3):e4773. PubMed ID: 19274084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice.
    Shin JH; Park JK; Lee DH; Quan FS; Song CS; Kim YC
    PLoS One; 2015; 10(6):e0130684. PubMed ID: 26086590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms.
    Zhou Y; Wu J; Hu X; Chen R; Lin X; Yin N; Lu C; Ye J; Zhao Y; Song X; Song Z; Wang J; Li Y; Li J; Zhang G; Sun M; Li H
    Hum Vaccin Immunother; 2023 Dec; 19(1):2189598. PubMed ID: 36994772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
    García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
    Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a thermally inactivated rotavirus vaccine in mice.
    Jiang B; Wang Y; Saluzzo JF; Bargeron K; Frachette MJ; Glass RI
    Hum Vaccin; 2008; 4(2):143-7. PubMed ID: 18382129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
    Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
    J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.